The 2022 ADA guidelines also have a section dedicated to the treatment algorithm for T2D when there is a compelling need to minimize weight gain or weight loss, suggesting that a glucagon-like peptide-1 (GLP-1) receptor agonist with good efficacy for weight loss or a sodium-glucose cotransporter-2 (SGLT-2) inhibitor be considered if first-line therapy with metformin and lifestyle modifications did not lead to adequate glycemic control in the patient [20]
Vigorous shaking destroys peptide structure through mechanical stress
Orphan Drug Designation : PWS is recognized as an orphan disease due to its rarity, a classification that often comes with incentives for pharmaceutical companies, such as market exclusivity, tax credits for clinical research, and waiver of marketing application fees, to develop treatments
I was skeptical at first, but ultimately decided to give it a try
Introducing exogenous probiotic strains can modify the homeostatic balance of resident gut microbial communities, potentially eliciting unforeseen immunological effects
The observation that replacement of the N-terminal norleucine with GABA yielded a compound with superior antidementia activity indicated that an N-terminal -amino group was not required for activity
